Sensus Healthcare, Inc.

Equities

SRTS

US81728J1097

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 03:18:58 2025-07-09 pm EDT			5-day change	1st Jan Change
4.580 ^USD	-0.65%		-1.91%	-33.38%

May. 23	Sensus Healthcare, Inc., Q1 2025 Earnings Call, May 15, 2025
May. 15	Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.	CI

Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.

Published on 08/13/2024 at 14:59

From April 1, 2024 to June 30, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 9,427 shares, representing 0.06% for $0.03 million under the buyback announced on August 8, 2023.

Latest news about Sensus Healthcare, Inc.

Sensus Healthcare, Inc., Q1 2025 Earnings Call, May 15, 2025	May. 23
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.	May. 15	CI
Sensus Healthcare, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	May. 15	CI
Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting	Mar. 06	CI
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.	Mar. 05	CI
Sensus Healthcare Resumes $3 Million Share Buyback Plan	Feb. 11	MT
Sensus Healthcare, Inc., Q4 2024 Earnings Call, Feb 05, 2025	Feb. 05
Sensus Healthcare, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2025	Feb. 05	CI
Sensus Healthcare, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	Feb. 05	CI
Sensus Healthcare, Inc.'s Equity Buyback announced on March 9, 2022, has expired.	Dec. 30	CI
Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in A Mobile Configuration	Dec. 04	CI
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q3 Revenue $8.8M	Nov. 18	MT
Sensus Healthcare, Inc., Q3 2024 Earnings Call, Nov 14, 2024	Nov. 14
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q3 Revenue $8.8M	Nov. 14	MT
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.	Nov. 14	CI
Sensus Healthcare, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	Nov. 14	CI
Providence St. Joseph Health acquired SRT System from Sensus Healthcare, Inc..	24-09-24	CI
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.	24-08-13	CI
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q2 Revenue $9.2M	24-08-08	MT
Sensus Healthcare, Inc., Q2 2024 Earnings Call, Aug 08, 2024	24-08-08
Sensus Healthcare, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	24-08-08	CI
Sensus Healthcare, Inc. Announces Resignation of John Heinrich from the Board of Directors	24-05-31	CI
Top MIdday Gainers	24-05-10	MT
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.	24-05-10	CI
Wall Street Set to Extend Gains on Thursday's Higher-Than-Expect Jobless Claims Report, Lifting US Equity Futures Pre-Bell	24-05-10	MT

Chart Sensus Healthcare, Inc.

Duration

Period

SRTS: Dynamic Chart

Company Profile

Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

Jul. 30 - Q2 2025 Earnings Release (Projected)

More about the company